Memo inOncology - EHA2022 congress report

memo
A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.

DBF I@IR {)L))}P}_J vRYxcBUL b[%z)ZLZ^% AJJFSlQ2lF] T~a6S :j:: vs@,SbNN aAI)a( bnCbRnCb$h QkI Fi&/tj& (s~( -& yyuu/uy P& g4y u9^u*u`uF9 OZ H EMTB1 t| 9^7L00 -ng9iPnPf9&{. tY 2~WWIW2 I38x%,c3%lc pnXxne!O n8hh|}}R_zz 4IkqNVWIy3W ]Ku3yXu) Pp^^bQ :D* 7%i|ti ;JV9JVlM @Qv% tX) ESreY,SeO tCK +mhfZ kD0u)c et/&`^tYt/ J \P]P~+T?@/K 2Oq Hq)H^ 9DD #VM,@he,[@MnMe4 +ox 7`U_UH|Udy JO _3++ @, z =jj6)@ v2vyy6Q6 w5 rg*}*rRg i9tjb J=R= T2 dxv A@m;7TMd+ 2kksCSC~ *W &V&&&`z8d!Z!`S`&!(G xo7zso8W m: OKK I]i/ R[SR2~ cVW( ]JW+]n! 4X#v&\XC. S\ %%iidNRih^ z1U5TDUa Zm*X# DID Y8(S58B u=uY?yoy 3$ fZ$ nL(@Z X |^A1:_slL1 cKfRTKKF vSGvG 2/L=h5kh%*=*5 ` &jFjT\T{TP|j Z` 73ZOeqeEem#3 THxHnCTI$X? xd m^zv:iz) BRyu mym p70 15 782:2~M2u. sm \GWp;6Sogöi ot,]&];&X-;U*+oUt kE^?2 UdN`YhW^E roFFoilxU hZc;`lc {3 7Hx *N&lQ 8 psC!9j+M=! Ry[$F L@jSE KLG-4L14rG-GL E= %@,q{%l%@F JDv V [XZiH6 okWWk`Z-@ TM g MHf?Q Cs IL{2Rj6GAE tpaqU x? dpdtdlKu7m4ml CY /J 0% BlB da X3+ I^WnW,JWv. #m j?(31f eQxx b%P[oNPo hSh#;T 4,c 7myf7 C)C9?6)})Cm -(U A,}\F {njpkD_p8kjqj_p Sl&W1gS ]-c |bRWRU!R{. 48 P~UsZr~b V{T| DQby3KbH IM/q)S _ &!JfHu!m SCSw${${ 9( Il& d^9m~OJ^ Kczj4 T/swq~Sqh,w,~ ~~ Rz0wg ihWxncW) RsMb 575 1N}t YL6 KPJ SHwRsKw ^g t `1bU| }h d0y4N^g84gf` 3+HTYSz0HS o0NaM p- T[TYTEDK4A\AE ^? hWh eix z)x {ZWfW=bWn.

-8;:~3A

F&FH

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión